LISATA THERAPEUTICS, INC. Effective Income Tax Rate Reconciliation, Tax Credit, Amount
LISATA THERAPEUTICS, INC. (LSTA) reported Effective Income Tax Rate Reconciliation, Tax Credit, Amount of $1.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxCredits · last filed 2023-05-09
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, amount for the quarter ending 2023-03-31 was $1.00M.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, amount for the quarter ending 2022-12-31 was $300.00K.
- LISATA THERAPEUTICS, INC. effective income tax rate reconciliation, tax credit, amount for fiscal 2022 was $700.00K.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 3 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 6 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 9 month | Effective Income Tax Rate Reconciliation, Tax Credit, Amount 12 month |
|---|---|---|---|---|
| 2023-03-31 | $1.00M 10-Q · filed 2023-05-09 | $1.30M derived: sum of 2 quarters · filed 2023-05-09 | ||
| 2022-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $700.00K 10-K · filed 2023-03-30 | ||
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |